These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 38467479)
1. The role of sex and drug use during adolescence in determining the risk for adverse consequences of amphetamines. Carrica LK; Gulley JM Adv Pharmacol; 2024; 99():125-144. PubMed ID: 38467479 [TBL] [Abstract][Full Text] [Related]
2. AMPed-up adolescents: The role of age in the abuse of amphetamines and its consequences on cognition and prefrontal cortex development. Westbrook SR; Carrica LK; Banks A; Gulley JM Pharmacol Biochem Behav; 2020 Nov; 198():173016. PubMed ID: 32828971 [TBL] [Abstract][Full Text] [Related]
3. Enduring deficits in sustained visual attention during withdrawal of intravenous methylenedioxymethamphetamine self-administration in rats: results from a comparative study with d-amphetamine and methamphetamine. Dalley JW; Lääne K; Theobald DE; Peña Y; Bruce CC; Huszar AC; Wojcieszek M; Everitt BJ; Robbins TW Neuropsychopharmacology; 2007 May; 32(5):1195-206. PubMed ID: 17035931 [TBL] [Abstract][Full Text] [Related]
4. NTP-CERHR monograph on the potential human reproductive and developmental effects of amphetamines. National Toxicology Program NTP CERHR MON; 2005 Jul; (16):vii-III1. PubMed ID: 16130031 [TBL] [Abstract][Full Text] [Related]
5. Increased risk of Parkinson's disease in individuals hospitalized with conditions related to the use of methamphetamine or other amphetamine-type drugs. Callaghan RC; Cunningham JK; Sykes J; Kish SJ Drug Alcohol Depend; 2012 Jan; 120(1-3):35-40. PubMed ID: 21794992 [TBL] [Abstract][Full Text] [Related]
6. Amphetamine-type stimulant use among men who have sex with men (MSM) in Vietnam: Results from a socio-ecological, community-based study. Vu NT; Holt M; Phan HT; Le HT; La LT; Tran GM; Doan TT; Nguyen TN; de Wit J Drug Alcohol Depend; 2016 Jan; 158():110-7. PubMed ID: 26656138 [TBL] [Abstract][Full Text] [Related]
7. Abuse of amphetamines and structural abnormalities in the brain. Berman S; O'Neill J; Fears S; Bartzokis G; London ED Ann N Y Acad Sci; 2008 Oct; 1141():195-220. PubMed ID: 18991959 [TBL] [Abstract][Full Text] [Related]
8. MDMA, methamphetamine and their combination: possible lessons for party drug users from recent preclinical research. Clemens KJ; McGregor IS; Hunt GE; Cornish JL Drug Alcohol Rev; 2007 Jan; 26(1):9-15. PubMed ID: 17364831 [TBL] [Abstract][Full Text] [Related]
9. The neurotoxicity of amphetamines during the adolescent period. Teixeira-Gomes A; Costa VM; Feio-Azevedo R; Bastos Mde L; Carvalho F; Capela JP Int J Dev Neurosci; 2015 Apr; 41():44-62. PubMed ID: 25482046 [TBL] [Abstract][Full Text] [Related]
12. Who are the new amphetamine users? A 10-year prospective study of young Australians. Degenhardt L; Coffey C; Carlin JB; Moran P; Patton GC Addiction; 2007 Aug; 102(8):1269-79. PubMed ID: 17624977 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological Treatment of Methamphetamine/Amphetamine Dependence: A Systematic Review. Siefried KJ; Acheson LS; Lintzeris N; Ezard N CNS Drugs; 2020 Apr; 34(4):337-365. PubMed ID: 32185696 [TBL] [Abstract][Full Text] [Related]
14. [The urinary screening and identification of amphetamines in clinical toxicology laboratory--VGH]. Lin WL; Deng JF; Chou LJ; Hung DZ; Tsai WJ Zhonghua Yi Xue Za Zhi (Taipei); 1991 Oct; 48(4):305-9. PubMed ID: 1659927 [TBL] [Abstract][Full Text] [Related]
15. DARK Side of Amphetamine and Analogues: Pharmacology, Syndromic Manifestation, and Management of Amphetamine Addiction. Baig AM ACS Chem Neurosci; 2018 Oct; 9(10):2299-2303. PubMed ID: 29671582 [TBL] [Abstract][Full Text] [Related]
17. Amphetamine detection during toxicology screening of a university medical center patient population. Bailey DN J Toxicol Clin Toxicol; 1987; 25(5):399-409. PubMed ID: 3323543 [TBL] [Abstract][Full Text] [Related]
18. Neuropsychiatric Adverse Effects of Amphetamine and Methamphetamine. Harro J Int Rev Neurobiol; 2015; 120():179-204. PubMed ID: 26070758 [TBL] [Abstract][Full Text] [Related]
19. Co-exposure of cannabinoids with amphetamines and biological, behavioural and health outcomes: a scoping review of animal and human studies. Daldegan-Bueno D; Maia LO; Glass M; Jutras-Aswad D; Fischer B Psychopharmacology (Berl); 2022 May; 239(5):1211-1230. PubMed ID: 34613429 [TBL] [Abstract][Full Text] [Related]
20. Maintaining class, producing gender: enhancement discourses about amphetamine in entertainment media. McKenna SA Int J Drug Policy; 2011 Nov; 22(6):455-62. PubMed ID: 21959088 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]